How much did Allogenetics raise?

Allogenetics raised $4.1M at Seed, announced 9 September 2026.

Who founded Allogenetics?

Oliver Ernst is Managing Director and CEO of Allogenetics.

What does Allogenetics do?

Allogenetics operates in HealthTech and is based in Germany.

FundedStartupsDaily / HealthTech / Allogenetics

Allogenetics raises $4.1M

Allogenetics announced a Seed round of $4.1M on 9 September 2026. The company operates in HealthTech and is based in Germany. It was founded by Oliver Ernst, Managing Director and CEO. Announced 44 days ago.

Raised

$4.1M

Stage

Seed

Industry

HealthTech

Country

Germany

Founder

Oliver Ernst

Managing Director and CEO, Allogenetics

LinkedIn profile allogenetics.de

Outreach angles

-Ernst is steering Allogenetics through its transition from preclinical research to clinical development for organ transplant gene therapy.
-Under Ernst, Allogenetics recently brought on Dr. Jeroen Rovers as Chief Medical Officer to help push ALG-115 toward first-in-human trials.
-Allogenetics just raised a 3.8 million euro pre-Series A after demonstrating 8-year survival in a pig lung transplant model without immunosuppressants.